Treatment of Neovascular AMD: Artificial Intelligence in Real-world Setting
Status:
Recruiting
Trial end date:
2022-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to implement quantitative assessment tools for the treatment of
active neovascular AMD patients in a real-world setting in order to provide advantages for
both patients (treatment burden) and healthcare system (scheduling visits/treatments).